Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ganglioside GM3 deficiency enhances mast cell sensitivity.
Komuro M, Mizugaki H, Nagane M, Morimoto M, Fukuyama T, Ogihara K, Naya Y, Yokomori E, Kaneshima K, Kawakami Y, Kamiie J, Shibata Y, Suzuki M, Shimizu T, Kawashima N, Okamoto M, Ikeda T, Yamashita T. Komuro M, et al. FEBS J. 2023 Sep;290(17):4268-4280. doi: 10.1111/febs.16806. Epub 2023 May 5. FEBS J. 2023. PMID: 37098812
Glucosylceramide in T cells regulates the pathology of inflammatory bowel disease.
Komuro M, Nagane M, Endo R, Nakamura T, Miyamoto T, Niwa C, Fukuyama T, Harashima H, Aihara N, Kamiie J, Suzuki R, Yamashita T. Komuro M, et al. Biochem Biophys Res Commun. 2022 Apr 9;599:24-30. doi: 10.1016/j.bbrc.2022.02.004. Epub 2022 Feb 3. Biochem Biophys Res Commun. 2022. PMID: 35168060
The novel sustained 3-hydroxybutyrate donor poly-D-3-hydroxybutyric acid prevents inflammatory bowel disease through upregulation of regulatory T-cells.
Suzuki R, Mishima M, Nagane M, Mizugaki H, Suzuki T, Komuro M, Shimizu T, Fukuyama T, Takeda S, Ogata M, Miyamoto T, Aihara N, Kamiie J, Kamisuki S, Yokaryo H, Yamashita T, Satoh T. Suzuki R, et al. Among authors: komuro m. FASEB J. 2023 Jan;37(1):e22708. doi: 10.1096/fj.202200919R. FASEB J. 2023. PMID: 36562544
Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severity.
Mitsui Y, Suzuki T, Kuniyoshi K, Inamo J, Yamaguchi K, Komuro M, Watanabe J, Edamoto M, Li S, Kouno T, Oba S, Hosoya T, Masuhiro K, Naito Y, Koyama S, Sakaguchi N, Standley DM, Shin JW, Akira S, Yasuda S, Miyazaki Y, Kochi Y, Kumanogoh A, Okamoto T, Satoh T. Mitsui Y, et al. Among authors: komuro m. Immunity. 2023 Aug 8;56(8):1939-1954.e12. doi: 10.1016/j.immuni.2023.06.013. Epub 2023 Jul 12. Immunity. 2023. PMID: 37442134
Non-clinical, quality and environmental impact assessments of cell and gene therapy products: Report on the 5th Asia Partnership Conference of Regenerative Medicine - April 7, 2022.
Tanaka T, Karasawa H, Yasumoto M, Choi BH, Chang R, Komuro M, Miyano M, Moriya Y, Muthusamy S, Okubo S, Takakura K, Tsurumaki Y, Watanabe T, Wen K, Yoneda T, Yuan TT, Nomura M. Tanaka T, et al. Among authors: komuro m. Cytotherapy. 2023 Jul;25(7):683-698. doi: 10.1016/j.jcyt.2023.03.012. Epub 2023 Apr 24. Cytotherapy. 2023. PMID: 37097265 Free article. Review.
Bortezomib-thalidomide-dexamethasone-cisplatin-doxorubicin-cyclophosphamide-etoposide as a Salvage and Bridging Regimen before Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma.
Togano T, Andoh S, Komuro M, Mitsui Y, Itoi S, Hirai R, Nakamura M, Tanimura A, Sekine R, Takeshita M, Miwa A, Hagiwara S. Togano T, et al. Among authors: komuro m. Intern Med. 2022 Nov 15;61(22):3329-3334. doi: 10.2169/internalmedicine.9097-21. Epub 2022 Apr 23. Intern Med. 2022. PMID: 35466165 Free PMC article.
73 results